Sumitomo Corporation Europe and existing investor Tekfen Ventures helped provide $28.5m for the gene-edited crop developer's latest round.
UK-based crop provider Tropic Biosciences closed a $28.5m series B round today featuring conglomerates Sumitomo and Tekfen, which invested through Sumitomo Corporation Europe and Tekfen Ventures respectively.
Temasek led the round, which included Genoa Ventures, Agronomics, Skyviews Life Science, Pontifax AgTech, Five Seasons Ventures, Emerald Technology Ventures, Bits x Bites and the UK Science & Innovation Seed Fund.
Founded in 2016, Tropic Biosciences uses gene editing to provide versions of tropical crops such as bananas or coffee it claims can…
